Special offer: Buy this report today and receive 50% off

With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market countries in order to sustain their revenue growth. While some countries, with double digit growth rates present tremendous opportunities, there are also many obstacles that need to be overcome.

Scope:

- Review of the key macroeconomic trends and business environment in analyzed countries

- In-depth analysis of the healthcare system dynamics in key emerging markets

- Analysis of the pharmaceutical market dynamics in analyzed emerging markets

- Overview of the outsourcing opportunities for key emerging markets

Highlights:

- Fast economic growth, increasing economic and political stability coupled with tremendous patient potential and increased Westernization of lifestyle present new opportunities for global pharmaceutical companies.

- Despite problematic intellectual property protection high market potential is attracting most multinational pharmaceutical companies.

- Healthcare system characteristics differ greatly between different emerging market countries.

- Greater state participation in healthcare provision is observed in all markets although growing disposable income and out-of-pocket expenditure are contributing to market growth.

- The changing medical needs of the emerging countries are favoring multinational companies: sales of anti-infective agents are slowing down and cancer drugs, immunomodulatory and respiratory drugs among others are growing at fast rates.

- With increasing purchasing power consumer preference for expensive new treatments is growing.


Reasons to Purchase:

- Identify the key trends that are driving and resisting the growth of the pharmaceutical market in key developing countries

- Understand the macroeconomic factors and healthcare system characteristics impacting the pharmaceutical market in the analyzed countries

- Gain insight into current market dynamics and opportunities and challenges for foreign companies wishing to enter these emerging markets



Table of Contents



407 pages

Publication Date : January 2008